IP Library Granted Patent US 7,642,338
Granted Patent B2
US 7,642,338 · App. 11/455,956 · Granted Jan 5, 2010

Tacrolimus standard and methods of using same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,642,338
App. No.
11/455,956
Granted
Jan 5, 2010
Kind
B2
Abstract

A composition and kit useful as a tacrolimus standard solution for immunoassays, and methods for making and using same. The composition and kits include a known amount of tacrolimus or a derivative thereof, and a non-specific protein capable of forming a complex with the tacrolimus or derivative thereof. The standard solution may be used to generate calibration curves for an immunoassay or to check the precision of an analytical instrument.

Claims (12)

1. A method for use in determining a concentration of tacrolimus or derivative thereof in a sample, said method comprising: providing a standard solution including a known amount of tacrolimus or a derivative thereof and a non-specific protein capable of forming a water soluble complex with the tacrolimus or derivative thereof, the non-specific protein being at least 95% fatty acid free and the ratio of non-specific protein to tacrolimus being in the range of 25,000:1 to 1000:1 on a weight basis wherein the non-specific protein is albumin or α 1 -acid glycoprotein; and performing an assay on the standard solution and on the sample to determine a concentration of tacrolimus or derivative thereof in the sample.

2. The method of claim 1 , wherein the standard solution further includes an emulsifier.

3. The method of claim 1 , wherein the standard solution further includes a hemolysate.

4. The method of claim 1 , wherein the solution comprises fatty acid free bovine serum albumin.

5. The method of claim 1 , wherein standard solution is free of alkanol solvents.

6. The method of claim 1 wherein the ratio of non-specific protein to tacrolimus is at least 2,000:1 on a weight basis.

7. The method of claim 1 wherein the ratio of non-specific protein to tacrolimus is at least 5,000:1 on a weight basis.

8. The method of claim 1 wherein the ratio of non-specific protein to tacrolimus is at least 10,000:1 on a weight basis.

9. A method for use in determining a concentration of tacrolimus or derivative thereof in a sample, said method comprising: providing a standard solution including a known amount of tacrolimus or a derivative thereof and a non-specific protein capable of forming a water soluble complex with the tacrolimus or derivative thereof, the non-specific protein being at least 95% fatty acid free and the ratio of non-specific protein to tacrolimus being at least 2000:1 on a weight basis wherein the non-specific protein is albumin or α 1 -acid glycoprotein; and performing an assay on the standard solution and on the sample to determine a concentration of tacrolimus or derivative thereof in the sample.

10. The method of claim 9 , wherein the standard solution further includes an emulsifier.

11. The method of claim 9 , wherein the solution comprises fatty acid free bovine serum albumin.

12. The method of claim 9 , wherein standard solution is free of alkanol solvents.

Assignments (2)
MERGER Recorded Mar 25, 2008
From: DADE BEHRING INC.
To: SIEMENS HEALTHCARE DIAGNOSTICS INC.
Reel/Frame 020690/0530 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 24, 2006
From: WEI, TIE Q.; HUDSON, DAVID R.
To: DADE BEHRING INC.
Reel/Frame 018000/0071 →